Navigation Links
Golden Meditech Announces HK$217 Million Private Equity Financing for Hospital Subsidiary

HONG KONG, Oct. 1 /PRNewswire-Asia/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 801.HK), a leading hi-tech medical device and healthcare service corporation in China, today announced that its hospital subsidiary - Golden Meditech Hospital Group (GMHG) has entered into an agreement to issue senior 5% redeemable convertible notes due in 2014 with an aggregate principal amount of US$28 million (equivalent to approximately HK$217 million). The monies raised will be used to accelerate business developments in China.

Under the agreement, GMHG will issue 15,747 new shares to investors upon full conversion, valuing the entire GMHG in excess of US$200 million. Upon full conversion, the note holder will hold approximately 13.61% of enlarged share capital of GMHG, and our holdings in GMHG will be diluted from current 60% to 51.8%.

Golden Meditech completed its strategic entry into China's hospital management and service market in June this year, and now owns the first nationwide management license granted by China government to a foreign entity.

Mr. KAM Yuen, Chairman of Golden Meditech said, "China's hospital management industry embraces a new era of development as the new medical reform aimed at separating hospital ownership and management and improving hospital operational efficiency will transform the hospital market entirely."

The successful private equity financing of GMHG have brought in renowned strategic investors from the healthcare industry. Through such a strategic collaboration, the group expects to accelerate the development of its hospital management operations in China, which in return generate significant profit contribution as well, he emphasized.

"Besides accelerating its expansion plan in China, this successful private equity financing will help create synergies effects between GMHG and other businesses we are currently operating. Such a move will help not only enhance our competitiveness, but also strengthen our strategic presence as one of the leading players in China's healthcare industry," said Mr. KAM.

Golden Meditech Company Limited (the "Company" or "Golden Meditech"; stock code: 801), together with its subsidiaries (collectively referred to as the "Group"), is a leading healthcare corporation in China. Golden Meditech operates an integrated portfolio of healthcare businesses including medical devices, healthcare services and natural herbal medicines. It has gained dominant market positions in all business segments. The first healthcare company listed outside Mainland China, the Group debuted on the Growth Enterprise Market (GEM) of the Stock Exchange of Hong Kong in December 2001 and migrated its listing to the Main Board in June 2009. The Group's mission is to contribute to people's health and welfare through the development and generalization of advanced medical technology and healthcare services, and to create value for its shareholders.

For enquiries, please contact the investor relations department of Golden Meditech Company Limited.

Address: 48/F., Bank of China Building, 1 Garden Road, Central, Hong Kong

Tel: +852 3605 8138

Fax: +852 3605 8181


SOURCE Golden Meditech Company Limited

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies
2. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
3. Golden scales
4. Golden nanocrown
5. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
6. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
7. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
8. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
9. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
10. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
11. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
Post Your Comments:
(Date:11/25/2015)... 2015 2 nouvelles études permettent d ... les différences entre les souches bactériennes retrouvées dans la plaque ... êtres humains . Ces recherches  ouvrent une nouvelle ... en charge efficace de l,un des problèmes de ... .    --> 2 nouvelles études permettent ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
Breaking Biology Technology:
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):